356 related articles for article (PubMed ID: 19584158)
21. (99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment.
Tsiapa I; Efthimiadou EK; Fragogeorgi E; Loudos G; Varvarigou AD; Bouziotis P; Kordas GC; Mihailidis D; Nikiforidis GC; Xanthopoulos S; Psimadas D; Paravatou-Petsotas M; Palamaris L; Hazle JD; Kagadis GC
J Colloid Interface Sci; 2014 Nov; 433():163-175. PubMed ID: 25128864
[TBL] [Abstract][Full Text] [Related]
22. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.
Yang L; Mao H; Wang YA; Cao Z; Peng X; Wang X; Duan H; Ni C; Yuan Q; Adams G; Smith MQ; Wood WC; Gao X; Nie S
Small; 2009 Feb; 5(2):235-43. PubMed ID: 19089838
[TBL] [Abstract][Full Text] [Related]
23. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.
Chen H; Wang L; Yu Q; Qian W; Tiwari D; Yi H; Wang AY; Huang J; Yang L; Mao H
Int J Nanomedicine; 2013; 8():3781-94. PubMed ID: 24124366
[TBL] [Abstract][Full Text] [Related]
24. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
26. Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.
Wang L; Zhong X; Qian W; Huang J; Cao Z; Yu Q; Lipowska M; Lin R; Wang A; Yang L; Mao H
J Magn Reson Imaging; 2014 Nov; 40(5):1071-81. PubMed ID: 25485347
[TBL] [Abstract][Full Text] [Related]
27. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
28. In Vivo Evaluation of a Miniaturized Fluorescence Molecular Tomography (FMT) Endoscope for Breast Cancer Detection Using Targeted Nanoprobes.
Yang H; Qian W; Yang L; Xie H; Jiang H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317217
[TBL] [Abstract][Full Text] [Related]
29. Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.
Kanazaki K; Sano K; Makino A; Shimizu Y; Yamauchi F; Ogawa S; Ding N; Yano T; Temma T; Ono M; Saji H
Nanomedicine; 2015 Nov; 11(8):2051-60. PubMed ID: 26238078
[TBL] [Abstract][Full Text] [Related]
30. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.
Hadjipanayis CG; Machaidze R; Kaluzova M; Wang L; Schuette AJ; Chen H; Wu X; Mao H
Cancer Res; 2010 Aug; 70(15):6303-12. PubMed ID: 20647323
[TBL] [Abstract][Full Text] [Related]
31. Improving sensitivity of magnetic resonance imaging by using a dual-targeted magnetic iron oxide nanoprobe.
Chen L; Xie J; Wu H; Zang F; Ma M; Hua Z; Gu N; Zhang Y
Colloids Surf B Biointerfaces; 2018 Jan; 161():339-346. PubMed ID: 29100127
[TBL] [Abstract][Full Text] [Related]
32. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
[TBL] [Abstract][Full Text] [Related]
33. Magnetic Resonance Imaging of Tumors with the Use of Iron Oxide Magnetic Nanoparticles as a Contrast Agent.
Semkina AS; Abakumov MA; Grinenko NF; Lipengolts AA; Nukolova NV; Chekhonin VP
Bull Exp Biol Med; 2017 Apr; 162(6):808-811. PubMed ID: 28429228
[TBL] [Abstract][Full Text] [Related]
34. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.
Peng XH; Qian X; Mao H; Wang AY; Chen ZG; Nie S; Shin DM
Int J Nanomedicine; 2008; 3(3):311-21. PubMed ID: 18990940
[TBL] [Abstract][Full Text] [Related]
35. Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.
Satpathy M; Wang L; Zielinski RJ; Qian W; Wang YA; Mohs AM; Kairdolf BA; Ji X; Capala J; Lipowska M; Nie S; Mao H; Yang L
Theranostics; 2019; 9(3):778-795. PubMed ID: 30809308
[TBL] [Abstract][Full Text] [Related]
36. Magnetic-nanoparticle-doped carbogenic nanocomposite: an effective magnetic resonance/fluorescence multimodal imaging probe.
Srivastava S; Awasthi R; Tripathi D; Rai MK; Agarwal V; Agrawal V; Gajbhiye NS; Gupta RK
Small; 2012 Apr; 8(7):1099-109. PubMed ID: 22328128
[TBL] [Abstract][Full Text] [Related]
37. Magnetic targeted near-infrared II PA/MR imaging guided photothermal therapy to trigger cancer immunotherapy.
Fu Q; Li Z; Ye J; Li Z; Fu F; Lin SL; Chang CA; Yang H; Song J
Theranostics; 2020; 10(11):4997-5010. PubMed ID: 32308764
[No Abstract] [Full Text] [Related]
38. Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors.
Hathaway HJ; Butler KS; Adolphi NL; Lovato DM; Belfon R; Fegan D; Monson TC; Trujillo JE; Tessier TE; Bryant HC; Huber DL; Larson RS; Flynn ER
Breast Cancer Res; 2011 Nov; 13(5):R108. PubMed ID: 22035507
[TBL] [Abstract][Full Text] [Related]
39. In vivo tomographic imaging with fluorescence and MRI using tumor-targeted dual-labeled nanoparticles.
Zhang Y; Zhang B; Liu F; Luo J; Bai J
Int J Nanomedicine; 2014; 9():33-41. PubMed ID: 24368885
[TBL] [Abstract][Full Text] [Related]
40. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
